MARKET

NSPRZ

Inspiremd
NSPRZ
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0180
0.0147
0.0022
-
InspireMD Director Paul Stuka Reports Acquisition of Common Shares
Reuters · 12/11 21:06
INSPIREMD ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 11/21 14:00
InspireMD Q3 revenue beats estimates on commercial launch of CGuard Prime
Reuters · 11/04 12:13
INSPIREMD NAMES PETER A. SOUKAS, M.D., AS CHIEF MEDICAL OFFICER
Reuters · 11/03 12:30
INSPIREMD ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 10/08 12:00
INSPIREMD ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 09/25 20:05
InspireMD Inc. Files Initial Statement of Beneficial Ownership for Director Danny L. Dearen
Reuters · 09/24 20:00
InspireMD Inc. Appoints Dan Dearen to Board of Directors Amid U.S. Launch of CGuard Prime
Reuters · 09/17 12:01
More

Webull offers Inspiremd stock information, including NASDAQ: NSPRZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSPRZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NSPRZ stock methods without spending real money on the virtual paper trading platform.